Tuesday, February 9, Iran began its COVID-19 vaccination campaign using Russia’s Sputnik V jab to fight the coronavirus pandemic.
Iran received the first batch of 10,000 doses from Russia last week, days after the Islamic Republic approved the drug for mass use. Iran also has unveiled its second indigenously-developed COVID-19 vaccine called the Razi Covo-Pars vaccine, which is the first injectable-inhalable vaccine of COVID-19 recombinant protein.
“We begin our national vaccination against the COVID-19 virus… (in) memory of the martyrdom of health workers,” Iran’s President Hassan Rouhani said, referring to medical personnel who have died from the disease.
Health Ministry Spokesman, Kianoush Jahanpour, the Islamic Republic has bought 2 million doses of Sputnik V.
The first doses of the Russian vaccine arrived last Thursday in Tehran, with two more shipments expected by February 18 and 28, according to Iranian authorities.
The Russian vaccine achieves a 91.6 percent efficacy against symptomatic forms of COVID-19, according to an analysis of clinical trials published in the top medical journal the Lancet a week ago.